S199: A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY EVALUATING THE EFFICACY AND SAFETY OF SINGLE AGENT BELANTAMAB MAFODOTIN VS POMALIDOMIDE PLUS DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (DREAMM-3)

oleh: Meletios A. Dimopoulos, Vania Hungria, Atanas Radinoff, Sosana Delimpasi, Gabor Mikala, Tamas Masszi, Jian LI, Marcelo Eduardo Capra, Morio Matsumoto, Neal Sule, Mary LI, Astrid Mckeown, Wei He, Shelley Bright, Brooke Currie, Julia Boyle, Joanna Opalinska, Katja Weisel